SGLTYT 10 MG
At Israelites Pharma, we deliver trusted, high-quality, and innovative pharmaceutical solutions, improving lives worldwide through science, sustainability, and a strong commitment to ethical healthcare advancement.
SGLTYT 10 MG
SGLTYT 10 MG is an advanced antidiabetic formulation designed to help control blood glucose levels and improve cardiovascular outcomes. It is widely prescribed for patients with type 2 diabetes for its proven efficacy, safety, and consistent therapeutic performance.
- Therapeutic Area: Cardiovascular / Diabetic
- Dosage Form: Tablet
- Categories: Cardiovascular, Diabetes
Product Strengths & Ingredients:
- SGLTYT 10 MG: Dapagliflozin 10 MG
Product Features:
- Blood Sugar Control: Promotes glucose excretion through urine, reducing elevated blood sugar levels.
- Heart Health: Supports cardiovascular health in diabetic patients.
- Weight Management: Helps reduce body weight and improve metabolic parameters.
- Proven Efficacy: Clinically tested for safety and consistent glucose control.
- Quality Assured: Produced under stringent GMP-certified conditions.
Product Details:
- Dosage Form: Tablet
- Route of Administration: Oral
- Pack Size: 10 Tablets per Strip, 10 Strips in Box
Usage & Dosage:
- Take as directed by a healthcare professional. Follow the prescribed dosage regimen carefully.
| Attribute | SGLTYT 10 MG | SGLTYT M 500 |
|---|---|---|
| Dosage Form | Tablet | Tablet |
| Strength | 10 MG | 10 MG + 500 MG |
| Packaging Options | 10 Tablets per Strip, 10 Strips in Box | 15 Tablets per Strip, 10 Strips in Box |
| Therapeutic Area | Cardiovascular / Diabetic | Cardiovascular / Diabetic |
| Storage | Cool, dry place | Cool, dry place |
| Recommended Use | As directed by a healthcare professional | As directed by a healthcare professional |
| Manufacturer | Synokem Pharmaceuticals Ltd, Uttarakhand, India | Akums Drugs & Pharmaceuticals Ltd, Uttarakhand, India |
| Ingredients | Dapagliflozin 10 MG | Dapagliflozin 10 MG + Metformin 500 MG |
| Image / Documents | Link | Link |
Manufacturer:
SGLTYT 10 MG and SGLTYT M 500 are manufactured by Synokem Pharmaceuticals Ltd and Akums Drugs & Pharmaceuticals Ltd, located in Uttarakhand, India.
Both facilities comply with Good Manufacturing Practices (GMP) and are equipped with advanced pharmaceutical production technology. They maintain stringent standards of quality, safety, and consistency across every batch, ensuring therapeutic effectiveness for diabetic care.
Marketer:
The products are marketed by Israelites Pharma Pvt Ltd, located at A/321, Royal Palms, Goregaon East, Mumbai, Maharashtra – 400065, India.
Israelites Pharma Pvt Ltd is dedicated to delivering safe, affordable, and high-quality pharmaceutical products. With a strong commitment to innovation and ethical practices, the company strives to enhance patient well-being and healthcare standards worldwide.
Quality Assurance:
Each batch of SGLTYT (10 MG and M 500) undergoes comprehensive quality checks throughout manufacturing, packaging, and storage. The products are tested for purity, potency, and stability following strict Standard Operating Procedures (SOPs) under expert supervision.
Research & Development:
Israelites Pharma collaborates with reputed R&D centers to develop innovative formulations for better glycemic control and cardiovascular safety. The SGLTYT range reflects continuous scientific research and technological advancement for modern diabetes management.
Patient Safety & Care:
At Israelites Pharma, patient safety is at the forefront. Each product, including SGLTYT 10 MG and SGLTYT M 500, is clinically tested, scientifically validated, and ethically manufactured to ensure reliability and trust among healthcare professionals and patients. The company is committed to providing evidence-based therapies that improve long-term diabetic health outcomes.
Similar Products
